← back to search

Sébastien Gouy

Inserm · FR
Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Intraperitoneal and Appendiceal Malignancies, and Reproductive Biology and Fertility.
h-index
45
citations
7,999
works
387
NIH funding
primary concept
Medicine
email

Recent publications

Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial
The Lancet Oncology 2024cited by 60position: middledoi
Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer
ACS Nano 2024cited by 32position: middledoi
Image-guided core biopsy for pelvic lesions of unknown origin.
2024cited by 0position: contributordoi
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial
Gynecologic Oncology 2023cited by 27position: middledoi
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
Cells 2020cited by 62position: middledoi
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors
The American Journal of Surgical Pathology 2020cited by 29position: middledoi
Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2020cited by 24position: middledoi
Brachytherapy: An overview for clinicians
CA A Cancer Journal for Clinicians 2019cited by 292position: middledoi
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers
European Journal of Cancer 2019cited by 40position: middledoi
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.
2019cited by 23position: contributordoi
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.
PubMed 2015cited by 35position: middle

Grants

No grants ingested yet.

Frequent collaborators

Philippe Morice · Institut Gustave Roussy5 papers (2019–2024) · 4 papers (2020–2024)Mojgan Devouassoux‐Shisheboran · Université Claude Bernard Lyon 13 papers (2020–2020)Patricia Pautier · Institut Gustave Roussy3 papers (2020–2024) · 2 papers (2020–2020) · 2 papers (2019–2024)Éric Deutsch · Inserm2 papers (2019–2024)Frédéric Guyon · Aristotle University of Thessaloniki2 papers (2015–2019)Alexandra Léary · Inserm2 papers (2020–2020)Cyrus Chargari · Radiothérapie Moléculaire et Innovation Thérapeutique2 papers (2019–2024) · 1 papers (2024–2024) · 1 papers (2020–2020)Naoual Bakrin · Université Claude Bernard Lyon 11 papers (2015–2015)Marc Deloger · Centre National de la Recherche Scientifique1 papers (2020–2020)Christophe Massard · Institut Gustave Roussy1 papers (2024–2024)Étienne Rouleau · Inserm1 papers (2020–2020)Marc Pocard · Centre National de la Recherche Scientifique1 papers (2015–2015) · 1 papers (2024–2024)Alberto Bossi · Université Paris-Saclay1 papers (2019–2019)Isabelle Dumas · Institut Gustave Roussy1 papers (2019–2019)